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Type I human skin collagenase (HSC-1) was localized in 
developing embryonic and fetal skin ranging from 6 to 20 
weeks estimated gestational age using an antigen-specific, 
affinity-purified, polyclonal antiserum to HSC-1 and an avi-
din-biotin alkaline phosphatase procedure. Double immuno-
labeling with monoclonal antibodies for Factor VIII-related 
antigen, type IV collagen, and the 68-kilodalton neurofila-
went subunit was performed using a direct peroxidase proce-
dure. 
By 8 weeks estimated gestational age, HSC-1 localized to 
the periderm, the basal cell epidermal keratinocytes, dermal 
fibroblasts, and surrounding extracellular matrix. At 12 
weeks estimated gestational age, HSC-1 immunolabeling 
showed a continued association with the epidermis and 
N orlnal turnover of fibrillar collagen is a slow, con-trolled process. A variety of collagenolytic en-zymes, described according to their physical prop-erties and their substrate specificity, has been implicated in maintaining the balance between 
collagen synthesis and degradation [1-4]. Human skin collagenase 
type I is a degradative metalloprotei~ase t1:at is syn~hesized as a 
54-kilodalton (kDa) preproenzyme with a smgle peptide sequence 
and secreted as a minor glycosylated 57 -kDa proenzyme and a major 
nonglycosylated 52-kDa proenzyme [5]. Proteolytic activation of 
the zymogen precursors results in the removal of the 81 amino acid 
amino-terminal sequence. Trypsinolysis ill vitro removes a 10-kDa 
peptide and produces two active species, 47 kDa and 42 kDa [1]. 
Cleavage of the inactive precursor procollagenase produces the ac-
tive enzyme collagenase, which shows marked affinity for fibrillar 
collagen [6]. 
Under nondenaturing conditions, type I human skin collagenase 
has substrate specificity for type I collagen [7], as well as for other 
types of collagen, including type VII collagen [8]. Collagenase binds 
to native type I collagen fibrils, and cleaves the al chain at the 
gly775-ile776 peptide bond and the a2 chain at a gly-leu peptide 
bond [9,10]. Human skin collagenase also has the ability to degrade 
denatured collagen, catalyzing cleavages at multiple gly-leu and 
gly-ile peptide bonds [11]. 
Collagenase and its precursors have been associated with a variety 
of cell types, localized to several regions of the human skin and 
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dermis. Dermal and subcutaneous blood vessels and the 
surrounding extracellular matrix were positive for HSC-l 
labeling. HSC-1 staining was also found around developing 
nerves and in association with dermal fibroblasts. In the de-
veloping hair follicle, HSC-1 was present in keratinocytes of 
the pre-germ, germ, hair peg, and bulbous hair peg. HSC-l 
immunoreactivity was also found in association with the-hair 
canal, the bulge, and the dermal papillae, but was absent from 
the fetal sebaceous gland. These data demonstrate the associ-
ation of HSC-1 with the development of interfollicular epi-
dermis, the dermal collagenous matrix, the process of angio-
genesis, the development of nerves, and hair follicle 
morphogenesis. Key words: angiogenesis/hair follicle morphogen-
esis.] Invest DermatoI102:951-957, 1994 
associated with normal and pathologic processes that involve tissue 
remodeling [12 -19]. Dermal fibroblasts if I vitro synthesize and se-
crete human skin collagenase [12] . A collagenase precursor is syn-
thesized by cultured epidermal keratinocytes [13] as well as by 
blood-derived monocytes and macrophages [14]. In vivo, collagen-
ase has been localized diffusely throughout the dermis [7]. The 
enzyme appears to be bound to collagen fibrils and is associated with 
dermal fibroblasts [12]. 
Human skin development can be divided into four stages accord-
ing to ultrastructural data [20-22]. The first is the late embryonic 
peri~d (6 - 8 weeks estimated gestational age [EGA]). The epidermis 
consists of an elevated periderm and a single basal cell layer. The 
dermis is rich in stellate-shaped, mesenchymal cells with abundant 
cell-to-cell junctions [23] and the fibrous collagen matrix in the 
dermis is sparse. At 6 weeks EGA, small capillaries, arterioles, and 
venules traverse through the cellular dermis. Epidermal appendages 
are not present. 
The epidermis of the second developmental stage, the early fetal 
period (9-13 weeks EGA), is characterized by addition of the stra-
tum intermedium. The dermis becomes rich in types I and III colla-
gen and has a deep boundary defined by neurovascular bundles. Hair 
pre-germs begin as local proliferations of basal keratinocytes. Der-
mal mesenchymal cells, referred to as the dermal condensation, 
collect beneath the pre-germ. 
The epidermis of the third developmental stage, the mid-fetal 
period (14- 18 weeks EGA), consists of a multiple-complex blebbed 
periderm, two to three intermediate cell layers, and a single basal 
cell layer. The diameter and size of dermal collagen fiber bundles 
increase, creating a fibrous dermis. Neurovascular bundles are 
present at all levels of the dermis. Hair germs with their associated 
mesenchymal cells elongate to hair pegs. 
In the fourth stage, the late fetal period (> 20 weeks EGA), the 
thickness of the epidermis increases, and the stratum granulosum 
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and stratum corneum form. The periderm regresses and is sloughed. 
During the mid- and late fetal stages, the follicle changes from a hair 
peg into a bulbous hair peg, in which a bulb forms at the deep end of 
the follicle and encloses the dermal papilla. The bulge, the attach-
ment site of the arrector pili muscle, and the sebaceous gland de-
velop superior to the hair bulb from populations of undifferentiated 
basal keratinocytes [24]. 
The developing skin must retain its plasticity to accommodate 
rapid growth and differentiation. Close regulation of collagen accu-
mulation and degradation must exist throughout human skin mor-
phogenesis. Studies of collagenase production by embryonic and 
fetal skin fibroblasts in culture [25] have suggested that the enzyme 
could be involved in the processes of embryonic and fetal skin mor-
phogenesis. In this report we have described collagenase expression 
in developing human skin in vivo, especially as its localization corre-
sponds to morphogenetic events such as hair follicle morphogene-
sis, angiogensis, and nerve migration. 
MATERIALS AND METHODS 
Tissue Normal human embryonic and fetal skin specimens of 57 -140 
days' EGA were obtained through the Central Laboratory for Human Em-
bryology at the University of Washington following Federal Guidelines and 
with institutional approval for the use of human material. Specimens were 
the result of elective abortions. Fetal age was estimated by maternal history, 
menstrual age, crown-rump length, foot length, and histologic examina-
tion. Multiple embryonic and fetal skin samples were taken from the trunk 
from each developmental stage, sectioned, and labeled with the human skin 
collagenase (HSC)-1 antiserum (late embryonic period, 28 tissue sections; 
early fetal period, 150 tissue sections; mid-fetal period, 45 tissue sections; and 
late fetal period, 16 tissue sections) . Additional tissue sections from each 
developmental stage were double labeled (late embryonic period, 12 tissue 
sections; early fetal period, 24 tissue sections; mid-fetal period, 28 tissue 
sections; and late fetal period, 12 tissue sections). 
Antibodies The polyclonal antibody to human skin collagenase was pre-
pared as described previously [12], using ammonium sulfate precipitation 
and affinity chromatography purification against immobolized human skin 
collagenase type I [1]. Monoclonal antibodies against Factor Vill-related 
antigen (von Willebrand factor; DAKO Corporation, Santa Barbara, CAl, 
the 68-kDa neurofilament subunit (DAKO Corporation), and type IV colla-
gen (Chemicon, Temecula, CAl were used in double labeling experiments. 
Gel Electrophoresis and Western Blotting Molecular weight stan-
dards (14.3-200 kDa) were purchased from Amersham International, 
Amersham, U .K. Purified HSC-l was prepared as described previously [1]. 
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Figure 1. Western blot of purified type I human skin collagenase (HSC-l) 
(lalle 1) and newborn foreskin epidermal extract (lane 2) immunostained 
with antisera to HSC-l . Purified HSC-l protein showed immunoreactivity 
at 57,52,47, and 42 kDa. The epidermal extract showed immunoreactive 
bands at 57 and 52 kDa; the 52-kDa band is more intense than the 57-kDa 
band. 
Newborn human foreskin epidermis was separated from dermis after incu-
bation in 10 mM ethylenediamine tetraacetic acid (EDTA). The epidermis 
was then extracted in 0.01 M Tris, pH 6.8. Samples were separated on a 10% 
sodium dodecyl sulfate (SDS) polyacrylamide gel by electrophoresis in the 
presence of 5% p-mercaptoethanol. Proteins were transferred clectropho-
retically from the gels to nitrocellulose membrane using a Bio-Rad Trans-
blot (BlORAD Laboratories, Palo Alto, CAl over an 18-h period at 4·C in 
0.025 M Tris-0.2 M glycine buffer, pH 7.6, and 30% methanol at 45 V. 
Blots were blocked with 2.5% non-fat dry milk, 0.01 M Tris, pH 7.6, 
washed, then incubated sequentially in polyclonal antibody to human skin 
collagenase (I : 2000) for 2 h, biotinylated goat anti-rabbit immunoglobulin 
{lg)G (1: 400, Vector, Burlingame, CAl for 1 h, and avidin-biotin peroxi-
dase (1 : 200; Zymed, South San Francisco, CAl for 1 h. Blots were then 
placed in chromagen (30 mg 4-chloronapthol, 10 ml methanol, 20 11130% 
H 20 2 in 50 ml Tris saline) for 10 min. All antibody incubations were done at 
Table I. Immunolocalization of HSC-l in Developing Embryonic and Fetal Skin 
Epidermis 
Basal layer 
Periderm 
Elevated/transitional 
Complex 
Stratum intermedium 
Dermis 
Blood vessels 
Nerves 
Dermal fibroblasts 
Extracellular matrix 
Pilosebaceous apparatus 
Pre-germ/germ epidermal cells 
Hair peg epidermal cells 
Bulbous hair peg epidermal cells 
Hair bulge 
Dermal papillae 
Inner root sheath 
• HSC-l immunoreactivity . 
• Not applicable. 
' No HSC-l immunoreactivity. 
Late Embryonic 
Period (6-8 weeks) 
+, 
+ 
NAh 
NA 
+ 
+ 
NA 
NA 
NA 
NA 
NA 
NA 
'Variability among vessels within single tissue sample. 
'Intense HSC-I immunoreactivity. 
Early Fetal 
Period (9-13 weeks) 
+ 
+ 
+ 
++ 
NA 
NA 
NA 
++ 
NA 
Mid-Fetal 
Period (14-18 weeks) 
+ 
NA 
NA 
+ 
-/++ 
+ 
++ 
++ 
NA 
++ 
++ 
NA 
++ 
NA 
Late Fetal 
Period (> 19 weeks) 
+ 
NA 
+ 
+ 
-/++ 
+ 
+ 
+ 
NA 
NA 
++ 
++ 
++ 
++ 
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Figure 2. Immunolabeling for HSC-l (a) and double immunolabeled for 
rype IV collagen (b) in skin from the late embryonic period, 57 days' EGA. 
HSC-l labeling is in the periderm and basal cell layer (a) , above the collagen 
IV-positive dermal-epidermal junction (b,d) . Staining is pericellular (a, 
arrow) and in the extracellular matix of the dermis. Rabbit serum control 
shows nonspecific fluorescence in the periderm (e). Bar, 50 pm. 
room temperature on a rotating platform and were followed by buffer 
washes. Control blots incubated with the primary antibody substituted by 
buffer gave negative results. 
lttUDunohistochemistry Skin samples were quick frozen in O.C-T. 
Compound (TissueTek, Elkhart, IN) in a slush of ethanol and dry ice and 
stored at - 70 · C- Six-micron - thick cryostat sections were cut and placed on 
3-aminopropyl triethoxysilane-coated glass slides. The sections were fixed 
in cold acetone for 5 min, rinsed in phosphate-buffered saline (PBS, pH 7.6) 
three times for 5 min, and subsequently incubated in PBS containing both 
1.3% normal goat and 0.3% normal horse serum for 30 min. Tissue sections 
were incubated sequentially in a) anti-human skin collagenase (1: 1500) or 
in control rabbit serum (1: 15,000, according to protein content) in 
PBS, 0.1 % bovine serum albumin (BSA), and 1 % normal goat serum for 1 h, 
b) biotinylated goat anti-rabbit IgG (1 : 800; Vector Laboratories, 
Burlingame, CAl for 30 minutes, c) alkaline phosphatase anti-biotin 
(1: 1000; Vector Laboratories) for 20 min, d) levamisole (25 mM in 20 mM 
NaHC0 3 ; Sigma) for 5 min to block endogenous alkaline phosphatase and, 
finally, e) exposed to the alkaline phosphatase substrate Vector Red (Vector 
Laboratories) for 10 min. Immunostained structures were recognized by a 
pink reaction product by light microscopy and by intense fluorescence when 
viewed by fluorescence microscopy using epifluoresence at a maximum 
absorption of 550 nm and a maximum emission of 575 nm. 
Double immunolabeled tissue sections were subsequently incubated with 
monoclonal antibodies and stained by the direct peroxidase method. Sections 
were first blocked in 1 % H20 2 for 30 min. Monoclonal antibodies to Factor 
VIII-related antigen (von Willebrand Factor), the 68-kDa neurofilament 
subunit, and type IV collagen were used at 1 : 750, 1: 75, and 1: 1200 dilu-
tions, respectively. Sections were incubated with the primary antibodies for 
60 min, exposed to the horse anti-mouse antibody conjugated with peroxi-
dase (1: 75) for 30 min, and rinsed extensively with PBS between incuba-
tions. Brown color was developed by incubation in 3,3' -diaminobenzidine-
HCl 0.06% (DAB), 0.05 M Tris, pH 7.6, 0.01 % H20 2 at room temperature 
for 20 min. Results were visualized with light microscopy. Rabbit serum 
labeling of tissue sections was negative. 
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RESULTS 
Immunoblotting Western blots of purified human skin colla-
genase and the human newborn epidermal extract were performed 
to confirm the specifi city of the polyclonal antiserum to HSC-1. 
Purified HSC-1 (Fig 1, lalle 1) showed immunoreactive bands of 
approximately 57, 52, 47, and 42 kDa, reflecting the presence 
of all four enzyme species, as reported earlier by Stricklin et al. 
[1]. The intensity of the 52-kDa band was significantly stronger 
than the 57-kDa band, and the 42-kDa band showed greater in-
tensity than the 47-kDa band. Both of the high molecular 
weight bands appeared stronger in intensity than the 47- or the 
42-kDa bands. As anticipated, the human epidermal extract (Fig 1, 
fall e 2) showed immunoreactivity at 57 and 52 kDa, the pro-
enzyme forms, but lacked 47- and 42-kDa bands. These data are in 
accordance with prior investigations that suggest adult epidermal 
keratinocytes in culture produce the proenzyme form of collage-
nase [13] . 
Immunohistology The results of the immunohistology are de-
scribed according to the period of skin development and summa-
rized in Table L 
Late Embryonic Period Embryonic skin stained positively with 
the antibody to HSC-1. Both layers of the epidermis stained in-
tensely (Fig 2a). The chromagen product appeared punctate and was 
located at the periphery of cells and throughout the cytoplasm. 
Labeling with type IV collagen defined the position of the basement 
membrane (Fig 2b). 
Scant punctate human skin collagenase immunostaining ap-
peared pericellulary (Fig 2a), presumably in association wi th fibro-
blasts, in the extracellular matrix of the dermis and the subcutaneous 
tissue. Double labeling for collagenase with antibodies that recog-
nized either Factor VIII-related antigen or neurofilaments demon-
strated that collagenase did not co-localize with blood vessels and 
developing nerves at this stage (data not shown). 
Early Petal Period lmmunolabeling with anti-HSC-1 of tissues 
9-13 weeks EGA showed continued expression of collagenase by 
the developing epidermis (Fig 3). Staining was intense, punctate, 
and appeared to be cytoplasmic. Punctate staining persisted in the 
periderm and in the epidermal basa l cells. 
D ermal and subcutaneous blood vessels co-localized with HSC-1 
immunostaining. Dense, punctate staining for collagenase appeared 
frequently within the cytoplasm and in association with the plasma 
membrane of the endothelium of developing blood vessels (Fig 3c) 
and closely co-localized with the vessel-associated Factor VIII-re-
lated an.tigen immunostaining (Fig 3d) . Immunostaining of vessels 
was variabl e in the associated matrix (Fig 3a-d) . 
Tissue sections double labeled with HSC-1 and neurofil ament 
antisera showed HSC-l immunoreactivity in cells (possibly 
Schwann cells) and matrix around developing nerves but did not 
label nerve fibers (Fig 3eJ). 
Dermal cells that expressed HSC-1 immunoreactivity (Fig 3c), 
but did not co-localize with Factor VIII-related antigen (Fig 3d) or 
the neurofilament subunit were likely dermal fibroblasts. Diffuse 
HSC-l immunostaining was also found in the collagenous matrix 
of the dermis. 
Hair germ keratinocytes were labeled with HSC-1 antiserum 
(Fig 3g). Intense, punctate staining was localized in the cell cyto-
plasm, whereas scant HSC- 1 immunoreactivity localized in the 
mesenchymal cell condensations (Fig 3g). 
Mid-Petal Period At 15 weeks' EGA, all layers of the developing 
fetal epidermis expressed HSC-1 (Fig 4a) . The periderm and inter-
mediate cell layers were characterized by intense cytoplasm.ic and 
peripheral, punctate HSC-1 iml11unostaining. The basal cells were 
immunoreactive for HSC-1 apically, but many of the bases of the 
keratinocytes were negative for HSC-1 label (Fig. 4a) . 
During this period dermal HSC-llabeling increased significantly 
(Fig 4a). Immunoreactivity was punctate and was found in associa-
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Figure 3. Human skin from the early fetal pe-
riod, 89 days' EGA, immunolabeled for HSC-l 
(a, c,e,g) and double immunolabeled for type IV 
collagen (b), factor VII-related antigen (d), 
and neurofilament (f). HSC-l immunolabe-
ling was found in basal, intermediate, and peri-
derm layers (a). Superficial dermal blood vessels 
were weakly labeled (a, arroUJ). Collagen IV 
immunoreactivity defined the dermal-epider-
mal junction (h, small arrow) and labeled super-
ficial dermal blood vessels (b, large arrow). HSC-
1 immunoreactivity co-localized with the 
vessel-associated Factor VIII - related antigen 
(c,d, small single arrow) and in surrounding 
extracellular matrix (c,d, small dOI/ble arrows). 
Dermal cells also co-localized with HSC-l 
immunostaining (c,d, large arrows). HSC-l 
immunoreactivity was found in the extracellu-
lar matix surrounding neurofilament immuno-
reactivity (e,l, small arrows) , but spared the nerve 
fibers (eJ, large arrows) . Hair germ keratinocytes 
and cells of the dermal condensations were im-
munopositive for HSC-l (g). Rabbit serum 
control labeling of tissue (with a collagen IV-
positive epiderm~l-dermal junction and endo-
thelial basement membrane; i) was negative 
(Ir). Bar, 50 ).Lm. 
tion with dermal cells (presumably fibroblasts) and in the collage-
nous extracellular matrix. 
HSC-l did not co-localize with vessels of the superficial dermis at 
this stage (defined by a collagen IV -positive basement membrane; 
Fig 4a,b). Deep dermal and subcutaneous blood vessels were charac-
terized by variable HSC-l immunolabeling. Some vessels, labeled 
with Factor VIII-related antigen, stained intensely with HSC-l 
and others were less intensely labeled (data not shown). Immuno-
reactivity was found in the cytoplasm of endothelial cells and in 
the extracellular matrix surrounding the developing vessels (Fig 
4c,d) . As in the early fetal period, developing nerves, labeled with 
antiserum to the 68-kDa neurofilament, showed HSC-l immu-
nostaining in cells and matrix surrounding the nerve fibers 
(Fig 4e,f). 
Keratinocytes of the elongated hair pegs stained with the HSC-l 
antiserum in a peripheral and punctate pattern, suggesting an as-
sociation between collagenase and the plasma membrane (Fig 
4c-h). The dermal cells at the tip of the peg, the presumptive 
dermal papilla cells, were intensely immunostained for HSC-l 
(Fig 4g,h). 
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Late Fetal Period All cell layers of the epidermis of the 
20-week-EGA fetus were HSC-l immunoreactive (Fig 5). The 
density of dermal labeling decreased in the late fetal period 
(Fig Sa). Dermal immunoreactivity was associated with cells (ap-
parently fibroblasts) and extracellular matrix (data not shown), 
and the association between HSC-l and developing blood vessels 
was variable. Superficial dermal vessels did not stain for HSC-l 
(Fig 5a,b), whereas many deep dermal and subcutaneous blood 
vessels were intensely labeled with the HSC-l antiserum (data 
not shown). The relationship between HSC-l and neurofilament 
immunoreactivity remained the same as in earlier developmental 
periods. 
Keratinocytes of the bulbous hair peg were immunoreactive for 
HSC-l, but the hair shaft was negative for label (Fig Sa). Intense 
immunostaining was located along the keratinized inner layer of the 
neck of many of the developing bulbous hair pegs (Fig 5Q,b). In-
tense, punctate immunoreactivity also characterized cells of the 
bulge (Fig 5c,d). Cells of the dermal papilla showed less intense 
immunostaining, but cells of the hair bulb were more intensely 
stained than in the previous developmental period (Fig 5e,f). 
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The cells of the sebaceous gland were devoid of label (data not 
sho'-Vn) . 
DISCUSSION 
Type I human skin collagenase is a degradative metalloproteinase 
that initiates the first step in the catalytic cleavage of collagen fibrils. 
The enzyme's degradative properties have been implicated in a 
number of physiologic and pathologic processes in which the exist-
ing collagen network is dismantled to allow for structural change. 
For example. in wound healing. it has been postulated that degrada-
tion of matrix by collagenase enables epidermal cell and dermal 
fibrob last migration, to facilitate reorganization of the traumatized 
tissue [15]. Human skin collagenase has also been immunolocalized 
in the stromal elements surrounding invasive basal cell carcinoma 
tumor islands [19]' where it may be involved in supporting tumor 
invas ion [26,27]. Our data suggest that collagenase plays a signifi-
cant role in different processes involved in embryonic and fetal skin 
morphogenesis. 
The regional and temporal distributions ofHSC-l immunoreac-
tivity in the skin of the developing human embryo and fetus are 
summarized in Table I. A variety of developing structures and mor-
phogenic processes appear to be associated with type I human skin 
collagenase. including the growth of the interfollicular epidermis, 
the development of the hair follicle, the growth of the dermal 
connective tissue . the process of angiogenesis and the development 
of nerves. 
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Figure 4. Human skin from the mid-fetal pe-
riod. 108 days' EGA. immunolabeled for 
HSC-l (a,c,e,g) and double immunolabeled for 
typeiV collagen (b,ll). Factor VIII - related an-
tigen (d), or neurofilaments (J) . HSC-l im-
munoreactivity was in all layers of the epider-
mis (a) , defined by a collagen IV-positive 
dermal-epidermal junction (h, small arrows) . 
Type IV collagen-positive superficial dermal 
blood vessels were negative for HSC-l immu-
nostaining (a,b, large arrows), but HSC-l im-
munoreactivity co-localized with the Factor 
VIII-related antigen immunostaining that de-
fined deep dermal blood vessels (c,d, large 
arrows). HSC-l immunolabeling was in the 
extracellular matrix surrounding dermal endo-
thelial cells (c,d, small arrows). HSC-l immu-
noreactivity was present around nerves (eJ, 
large arrows) and spared the fibers (eJ, small 
arrows). Keratinocytes of the hair follicle were 
outlined by a type IV collagen-positive base-
ment membrane (g,", small arrows) and seen in 
cross-section were positively stained for HSC-
1 (c-f). Cells of the dermal condensations 
(g,lt , large arrows) also were positive for HSC-l 
immunolabel. Rabbit serum control labeling of 
tissue was negative, whereas basement mem-
branes were stained for collagen IV (i,j). Bar, 
SO/-lm. 
Embryonic and fetal epidermal keratinocytes appear to be in-
volved in collagenase synthesis. Intense. punctate immunoreactivity 
characterized all layers of the developing epidermis. This distribu-
tion is supported by studies suggesting that postnatal epidermal 
keratinocytes produce a collagenase precursor ;/1 vitro and ;/'1 I/;VO 
[13.28.29]. Petersen [13] found that there is no functional or bio-
chemical difference between the collagenase produced by adult 
epid~rmal keratit;ocytes and that produced by dermal fibroblast~. 
If thiS relationship holds true in the embryo and the fetus, epI-
dermally associated collagenase may playa role in early cell mo-
tility and in human skin morphogenesis. The enzyme may be pro-
duced in epidermal keratinocytes and stored intracellularly until 
appropriate cues signal its release. Collagenase may allow for epi-
dermal expansion and it may be functional in allowing proliferating 
keratinocytes to grow into the dermis to form the developing hair 
follicle. 
As early as 11 weeks' EGA. HSC-l is associated with the pre-
germ keratinocytes. We suggest that collagenase may function in 
the collagen-rich dermis to enable the downward growth of the hair 
follicle, and it may degrade the collagen fibers at the tip of the 
growing hair germ and hair peg to allow for the close approxima-
tion of the mesenchymal condensation (the presumptive dermal 
papilla) . The close physical relationship between the dermal papilla 
and the follicular cells is thought to be important in hair follicle 
morphogenesis [30]. 
The fibroblasts of the dermal papilla are also a site of HSC-l 
immunoreactivity. The cells of the mesenchymal condensations 
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Figure 5. Human skin from the late fetal pe-
riod, 140 days' EGA, immunolabeled for HSC-
1 (a,c,e) and double immunolabeled for type IV 
collagen (b,dJ) . HSC-1 immunoreactivity was 
found in the stratified epidermis (above the col-
lagen IV-positive dermal-epidermal junction, 
a,b) . Collagen IV also defined HSC-1-negative 
structures in the superficial dermis (a,b, large 
arrows). Dense HSC-l label was located along 
the keratinized inner layer of the hair peg (a,b, 
small arrows) . Keratinocytes of the bulge 
(boundaries defined by a type IV collagen-posi-
tive basement membrane) retained HSC-l im-
munoreactivity (c,d, arrows) . Keratinocytes of 
the bulb and mesenchymal cells of the dermal 
papillae (limits defined by a type IV collagen-
positive basement membrane zone) were posi-
tive for HSC-1 immunolabeling (e,f, arrows) . 
Rabbit serum control labeling of tissue was neg-
ative, along with positive labeling for type IV 
collagen (g, h) . Bar, 50 11m. 
may secrete collagenase into the surrounding dermal matrix 
to facilitate the invagination of the pilosebaceous apparatus 
[31,32]. 
The intense band of immunoreactivity lining the inner root sug-
gests that collagenase may playa role in cell motility and, subse-
quently, the eruption and release of the developing hair and the 
expansion of the developing hair. 
At approximately 11 weeks EGA, during active vasculogenesis 
[22], collagenase immunolabeling localizes in the cells of develop-
ing dermal blood vessels and in the surrounding extracellular ma-
trix. These findings are consistent with studies that suggest a func-
tional role of endothelial cell-derived collagenase in the proteolytic 
degradation of extracellular matrix in the process of angiogenesis 
and neovascularization [33-38]. Our data suggest that collagenase 
is produced by endothelial cells, although the enzyme found in 
association with the extracellular matrix may be of endothelial 
origin or may have been produced by surrounding dermal fibro-
blas ts. 
We observed heterogeneity of blood vessel HSC-l immuno-
staining in the early, mid-, and late fetal periods. Between 9 and 20 
weeks EGA, the vascular network is expanding; the vessels are 
branching extensively and the diameters of the established vessels 
are growing [22]. If vessel-associated matrix degradation is occur-
ring, the coincidental decrease in HSC-l immunoreactivity sug-
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gests that other matrix-degrading enzymes may be ac tive and 
that the composition of the matrix may be different from that of 
earlier stages. For instance, it is known that the blood vessels in 
embryonic and fetal skin are found in association with increasing 
amounts of types IV and V collagen [37] and these collagens are 
degraded by different members of the matrix metalloproteinase 
gene family. 
Collagenase was also found in the area surrounding nerves, but 
did not appear to be expressed by the neurites per se. Because the 
immunostaining patterns did not distinguish whether the immuno-
staining co-localized within perineural cells, the neurovascular 
bundle-associated endothelial cells, the surrounding dermal fibro-
blasts, or the extracellular collagen matrix, the role of collagenase in 
the development of nerves remains unclear. 
Even though we have been able to associate human skin collagen-
ase with a variety of developing structures, questions remain as to 
the precise location of the enzyme in the cell. From our data it 
appears to be both cytoplasmic and membrane associated. Indeed, 
the kinetics of synthesis and secretion by adult skin fibroblasts sug-
gest that little, but a measureable amount, of the enzyme is stored 
intracellulary [1,2]' and, in addition, there may be membrane-asso-
ciated enzyme. It is now essential to determine the mechanisms 
controlling expression and trafficking of these putative protease 
forms during development. 
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